Knowing is everything.
Too much is at stake to rely on guesses and hunches. That’s why we provide data-driven critical thinking and analysis to deliver the scientific validation and actionable insights you need—before you invest too much or plan too far ahead.
Through rigorous, fact-based market analysis, we can help you avoid costly pitfalls, increase value, and reduce time and investment before every stage of your medical technology market development.:
- Clinical trials
- Marketing and market development investments
- Strategic partnerships, exit, or acquisitions
Develop powerful, defensible, strategies that your organization and stakeholders will get behind—and, ultimately, will move your market.
Whether you’re a start-up or a global enterprise, we can help you realize the full market potential of your medical technology.
The Science of Market Development.
Basic market data may be readily available but it’s rarely clear, consistent, or actionable. Get the rigorous, reliable, objective insights and analysis you can trust to help you make the most difficult business and product development decisions.
Of the hundreds of things you could do, we’ll help uncover the two or three that matter most.
We bring you objectivity, clarity, and focus. We understand what works and what doesn’t for medical technologies. Of the hundreds of things you could do, we help uncover the two or three that matter most.
Many organizations have a strategic need to enhance their market development capabilities and competencies. We can integrate our proven methods, tools and processes to help you take full advantage of your market growth opportunities.
Disease Dynamics Reports show you the numbers BEHIND the starting point of most disease models. Using our proprietary methods and analysis, we’ve created a single document that synthesizes information from the entire body of clinical literature on a given disease into a comprehensive and cohesive disease landscape.
Navigant—a specialized, global professional services firm—acquired Dymedex on September 1st. The entire Dymedex team, including founders Joseph Galatowitsch and Ross Meisner, joined the Navigant Life Sciences practice within the company’s Healthcare segment. Learn more
eNewsletter Sign Up
Receive pertinent insights, resources, case studies and upcoming events.Sign Up for our eNewsletter